{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:25:41Z","timestamp":1785882341807,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jid.2016.08.037","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T18:16:41Z","timestamp":1477073801000},"page":"631-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis"],"prefix":"10.1016","volume":"137","author":[{"given":"Takashi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Saigusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trojanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.08.037_bib1","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4529","article-title":"Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1","volume":"16","author":"Akamata","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2016.08.037_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.39062","article-title":"Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability","volume":"67","author":"Akamata","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2016.08.037_bib4","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2016.08.037_bib5","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/art.27647","article-title":"Animal models of systemic sclerosis: prospects and limitations","volume":"62","author":"Beyer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2016.08.037_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000381099","article-title":"Glycyrrhizin attenuates proinflammatory cytokines through a peroxisome proliferator-activated receptor-g-dependent mechanism and experimental vasospasm in a rat model","volume":"52","author":"Chang","year":"2015","journal-title":"J\u00a0Vasc Res"},{"key":"10.1016\/j.jid.2016.08.037_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3899\/jrheum.120416","article-title":"Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis","volume":"40","author":"Cutolo","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib9","first-page":"S3","article-title":"Systemic sclerosis: from pathogenesis to targeted therapy","volume":"33","author":"Denton","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fphar.2015.00215","article-title":"Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats","volume":"6","author":"Gao","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jid.2016.08.037_bib11","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s10067-012-2074-5","article-title":"Bosentan fosters microvascular de-remodelling in systemic sclerosis","volume":"31","author":"Guiducci","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/annrheumdis-2014-207109","article-title":"Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis","volume":"75","author":"Huang","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2016.08.037_bib13","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/j.1523-1755.2005.00358.x","article-title":"Antibodies against macrophages that overlap in specificity with fibroblasts","volume":"67","author":"Inoue","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jid.2016.08.037_bib14","first-page":"835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","author":"Jimenez","year":"2013","journal-title":"ISRN Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/ptr.4800","article-title":"The anti-angiogenic activities of glycyrrhizic acid in tumor progression","volume":"7","author":"Kim","year":"2013","journal-title":"Phytother Res"},{"key":"10.1016\/j.jid.2016.08.037_bib16","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2016.08.037_bib17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor b\u2013at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib18","first-page":"872139","article-title":"Glycyrrhizic acid in the treatment of liver diseases: literature review","volume":"2014","author":"Li","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jid.2016.08.037_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jep.2013.04.021","article-title":"Immunoregulatory effects of glycyrrhizic acid exerts anti-asthmatic effects via modulation of Th1\/Th2 cytokines and enhancement of CD4(+)CD25(+)Foxp3+ regulatory T cells in ovalbumin-sensitized mice","volume":"148","author":"Ma","year":"2013","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.jid.2016.08.037_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib21","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2016.08.037_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.lfs.2008.07.023","article-title":"Glycyrrhizin and its metabolite inhibit Smad3-mediated type I collagen gene transcription and suppress experimental murine liver fibrosis","volume":"83","author":"Moro","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.jid.2016.08.037_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pharmthera.2013.11.001","article-title":"An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies","volume":"141","author":"Musumeci","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jid.2016.08.037_bib26","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.08.037_bib27","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2016.08.037_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.1017547108","article-title":"Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver","volume":"108","author":"Osterreicher","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2016.08.037_bib29","first-page":"1292","article-title":"Effects of 18a-glycyrrhizin on TGF-b1\/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis","volume":"8","author":"Qu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jid.2016.08.037_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2015.05.005","article-title":"Latent TGF-b-binding proteins","volume":"47","author":"Robertson","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2016.08.037_bib31","doi-asserted-by":"crossref","first-page":"15136","DOI":"10.1073\/pnas.1520997112","article-title":"Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis","volume":"112","author":"Saigusa","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2016.08.037_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjd.14183","article-title":"Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions","volume":"174","author":"Saigusa","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.08.037_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10152","article-title":"Latent TGF-b structure and activation","volume":"474","author":"Shi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jid.2016.08.037_bib34","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.1038\/srep14871","article-title":"FSP1(+) fibroblast subpopulation is essential for the maintenance and regeneration of medullary thymic epithelial cells","volume":"5","author":"Sun","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2016.08.037_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.mehy.2013.07.026","article-title":"Glycyrrhizic acid confers neuroprotection after subarachnoid hemorrhage via inhibition of high mobility group box-1 protein: a hypothesis for novel therapy of subarachnoid hemorrhage","volume":"81","author":"Sun","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jid.2016.08.037_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2016.08.037_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jid.2015.10.058","article-title":"Tamibarotene ameliorates bleomycin-induced dermal fibrosis by modulating phenotypes of fibroblasts, endothelial cells, and immune cells","volume":"136","author":"Toyama","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.08.037_bib38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.intimp.2012.08.013","article-title":"Glycyrrhizin regulates CD4+ T cell response during liver fibrogenesis via JNK, ERK and PI3K\/AKT pathway","volume":"14","author":"Tu","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jid.2016.08.037_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/resp.12655","article-title":"Regulation of Th1\/Th2 balance through OX40\/OX40L signalling by glycyrrhizic acid in a murine model of asthma","volume":"21","author":"Wu","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.jid.2016.08.037_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00403-005-0635-z","article-title":"The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?","volume":"297","author":"Yamamoto","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2016.08.037_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-014-0148-4","article-title":"Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats","volume":"15","author":"Yang","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.jid.2016.08.037_bib42","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/annrheumdis-2013-204256","article-title":"Inhibition of\u00a0casein kinase II reduces TGFb induced fibroblast activation and ameliorates experimental fibrosis","volume":"74","author":"Zhang","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16325374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16325374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T12:31:58Z","timestamp":1543321918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16325374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0022202X16325374"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.08.037","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}